Inventor · disambiguated record
Daya Verma
Also filed as: VERMA DAYA · VERMA DAYA D
5 granted patents·9 pending applications·26 citations·filing 2006–2020
78Inventor score
Top patents by PatentIndex Score
14 records- 0186US9763941B2Method of treating melanoma by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamateARRAY BIOPHARMA INC·Filed 2016·Granted Sep 19, 2017·6 cites·22 claims
- 0283US9387208B2Pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamateVERMA DAYA·Filed 2012·Granted Jul 12, 2016·11 cites·19 claims
- 0382US10258622B2Method of treating colorectal cancer by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)pheny1)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl) carbamateARRAY BIOPHARMA INC·Filed 2017·Granted Apr 16, 2019·3 cites·22 claims
- 0477US9744137B2Topiramate compositions and methods of enhancing its bioavailabilityNANGIA AVINASH·Filed 2007·Granted Aug 29, 2017·6 cites·25 claims
- 0563US2007003621A1Dosage forms for movement disorder treatmentSPHERICS INC·Filed 2006·Application pending·0 cites
- 0663US2008299204A1Dosage forms for movement disorder treatmentSPHERICS INC·Filed 2006·Application pending·0 cites
- 0762US10561654B2Pharmaceutical formulations of (S)-methyl(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamateARRAY BIOPHARMA INC·Filed 2018·Granted Feb 18, 2020·0 cites·14 claims
- 0855US2008131492A1Dosage forms for movement disorder treatmentSPHERICS INC·Filed 2007·Application pending·0 cites
- 0953US2007148238A1Dosage forms for movement disorder treatmentSPHERICS INC·Filed 2006·Application pending·0 cites
- 1046US2010316712A1Pharmaceutical compositions for treatment of parkinson's disease and related disordersCOMBINATORX INC·Filed 2007·Application pending·0 cites
- 1145US2021169854A13'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid and its salts formulationNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1241US2014044788A1Solid Oral Formulations of a PyridopyrimidinoneVERMA DAYA·Filed 2013·Application pending·0 cites
- 1336US2017209455A1Solid Pharmaceutical Composition Comprising PI3K-InhibitorNOVARTIS AG·Filed 2015·Application pending·0 cites
- 1432US2011287069A1Solid oral formulations of a pyridopyrimidinoneVERMA DAYA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daya Verma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →